1,2-Dichloroethane → HCID 56597560, 화합물

HRID 475956

반응식

HRID 475956 반응식
[CH:1]1([C:4]2[CH:5]=[C:6]([C:16]([OH:18])=O)[C:7]3[CH:12]=[N:11][N:10]([CH:13]([CH3:15])[CH3:14])[C:8]=3[N:9]=2)[CH2:3][CH2:2]1.[NH2:19][CH2:20][C:21]1[C:22](=[O:31])[NH:23][C:24]([CH3:30])=[CH:25][C:26]=1[CH:27]([CH3:29])[CH3:28].C(O)(C(F)(F)F)=O.C1C=NC2N(O)N=NC=2C=1.C(Cl)CCl.CN1CCOCC1>CN(C=O)C>[CH:1]1([C:4]2[CH:5]=[C:6]([C:16]([NH:19][CH2:20][C:21]3[C:22](=[O:31])[NH:23][C:24]([CH3:30])=[CH:25][C:26]=3[CH:27]([CH3:28])[CH3:29])=[O:18])[C:7]3[CH:12]=[N:11][N:10]([CH:13]([CH3:14])[CH3:15])[C:8]=3[N:9]=2)[CH2:2][CH2:3]1

참가 물질

8

실험 절차

The title compound was prepared in the same manner as described in example 7 from 6-cyclopropyl-1-(1-methylethyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid (250 mg, 1.019 mmol), 3-(aminomethyl)-6-methyl-4-(1-methylethyl)-2(1H)-pyridinone.TFA (300 mg, 1.019 mmol), HOAT (208 mg, 1.529 mmol), EDC (293 mg, 1.529 mmol), N-methylmorpholine (0.448 mL, 4.08 mmol), and DMF (6 mL), wherein the reaction time was 48 h. The final product was collected following a basic extraction (to remove residual starting material) as a white solid, 30 mg (7%). LCMS E-S (M+H)=408.3. 1H NMR (400 MHz, DMSO-d6) δ ppm 0.95-1.16 (m, 10H), 1.38-1.54 (m, 6H), 2.16 (s 3H), 2.19-2.30 (m, 1H), 3.12-3.29 (m, 1H), 4.29-4.48 (m, 2H), 5.03-5.21 (m, 1H), 6.03 (s, 1H), 7.39 (s, 1H), 8.21 (s, 1H), 8.63-8.81 (m, 1H), 11.56 (s, 1H).

후처리

  1. customThe final product was collected
  2. extractiona basic extraction (to remove residual starting material) as a white solid, 30 mg (7%)

출처 및 근거

ORD 기록
ord-0305a7130ba7429a81964ddb48af7e6c
출처 데이터셋
uspto-grants-2014_01
특허 번호
US08637509B2

연결된 노트

불러오는 중…